Enhanced lysosomal degradation maintains the quiescent state of neural stem cells by Kobayashi, Taeko et al.
Title Enhanced lysosomal degradation maintains the quiescent stateof neural stem cells
Author(s)
Kobayashi, Taeko; Piao, Wenhui; Takamura, Toshiya; Kori,
Hiroshi; Miyachi, Hitoshi; Kitano, Satsuki; Iwamoto, Yumiko;
Yamada, Mayumi; Imayoshi, Itaru; Shioda, Seiji; Ballabio,
Andrea; Kageyama, Ryoichiro




© The Author(s) 2019. This article is licensed under a Creative
Commons Attribution 4.0 International License, which permits
use, sharing, adaptation, distribution and reproduction in any
medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The
images or other third party material in this article are included
in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons license and your
intended use is not permitted by statutory regulation or exceeds
the permitted use, you will need to obtain permission directly






Enhanced lysosomal degradation maintains the
quiescent state of neural stem cells
Taeko Kobayashi 1,2,3*, Wenhui Piao1,3, Toshiya Takamura1, Hiroshi Kori4, Hitoshi Miyachi1, Satsuki Kitano1,
Yumiko Iwamoto1, Mayumi Yamada1,3,5, Itaru Imayoshi1,3,5, Seiji Shioda6, Andrea Ballabio 7 &
Ryoichiro Kageyama 1,2,3,5*
Quiescence is important for sustaining neural stem cells (NSCs) in the adult brain over the
lifespan. Lysosomes are digestive organelles that degrade membrane receptors after they
undergo endolysosomal membrane trafficking. Enlarged lysosomes are present in quiescent
NSCs (qNSCs) in the subventricular zone of the mouse brain, but it remains largely unknown
how lysosomal function is involved in the quiescence. Here we show that qNSCs exhibit
higher lysosomal activity and degrade activated EGF receptor by endolysosomal degradation
more rapidly than proliferating NSCs. Chemical inhibition of lysosomal degradation in qNSCs
prevents degradation of signaling receptors resulting in exit from quiescence. Furthermore,
conditional knockout of TFEB, a lysosomal master regulator, delays NSCs quiescence in vitro
and increases NSC proliferation in the dentate gyrus of mice. Taken together, our results
demonstrate that enhanced lysosomal degradation is an important regulator of qNSC
maintenance.
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Somatic stem cells in adult tissues maintain the capacity toself-renew and produce progeny through the lifespan. Aswith other somatic stem cells, the majority of neural stem
cells (NSCs) in the adult mammalian brain exist in a quiescent
state, which is essential for maintenance of stem cell pools over
long periods of time1,2. In the adult mouse brain, NSCs primarily
reside in two regions, the hippocampal dentate gyrus (DG) and
the subventricular zone (SVZ) of the lateral ventricle. Quiescent
NSCs (qNSCs) remain in the G0 phase and re-enter the cell cycle
after receiving activation signals; once activated, they generate
proliferating NSCs (active NSCs; aNSCs), which differentiate into
transit-amplifying cells and ultimately into mature neurons3.
Extensive studies have identified the factors, signaling pathways,
and metabolic states underlying the transition between NSC
proliferation and quiescence in vivo and in vitro4–7. However, the
role of proteostasis in the regulation of this process remains
poorly understood.
Proteolysis, mediated primarily by the ubiquitin–proteasome
and autophagy–lysosome pathways, is essential for cellular pro-
teostasis8. Elevated proteasomal activity is crucial for stem cell
identity, and prevents differentiation and senescence in human
embryonic stem cells9. Autophagic activity decreases over the
course of aging in muscle stem cells, resulting in loss of stemness
in geriatric satellite cells10. These observations suggest that global
proteolysis preserves stemness by governing basal proteostasis.
Notably, qNSCs in the DG express abundant functional mem-
brane receptors, which are required for aNSCs, despite remaining
in a resting state11, implying that specifically regulated proteolysis
is required to maintain quiescence in these cells. Recent work
showed that lysosomes are enriched in qNSCs, compared to
aNSCs in the SVZ12, in which aged qNSCs accumulate more
protein aggregates in lysosomes while a decrease in the abun-
dance of aggregates causes qNSCs to rejuvenate. However, the
functional role of lysosomes in qNSCs, especially at the transition
between aNSCs and qNSCs, is not fully understood. In this study,
we show that lysosomal activity is elevated in qNSCs, and that
inhibition of this activity leads to exit from quiescence via a
process dependent on activation of epidermal growth factor
(EGF) and Notch signaling. Conversely, lysosomal activation in
aNSCs promotes exit from proliferation. In vitro, activated EGF
receptor (EGFR) is more rapidly degraded in qNSCs than in
aNSCs. Furthermore, knockout of Tfeb, a master regulator of
lysosomal biogenesis, in NSCs delays not only the reduction in
EGF and Notch signaling but also the entry into quiescence
in vitro. Importantly, in vivo, conditional knockout of Tfeb in
adult NSCs increases the number of proliferating NSCs, along
with the levels of activated EGFR and Notch1 in the DG of the
hippocampus. These findings demonstrate that enhanced lyso-
somal activity enables NSCs to remain poised in the quiescent
state by rapidly removing unnecessary or undesirable cellular
signals.
Results
NSCs increase lysosomal activity when they enter quiescence.
We first investigated whether proteasomal activity differs sig-
nificantly between quiescent and proliferating NSCs (Fig. 1a). For
these experiments, we used an in vitro culture model of NSCs, an
NSC line established in our previous study13 (see Methods) as
well as other NSCs including NS5, ES cell-derived NSCs, and
NSCs from adult mouse brain (adNSC)14 (Supplementary
Fig. 1a), in which quiescence could be induced by exposure to
BMP4 for 3 days14 (Supplementary Fig. 1b). To measure pro-
teolysis in NSCs in vitro, we monitored three types of proteaso-
mal peptidase activities (chymotrypsin-, trypsin-, and caspase-
like) in whole-cell lysates prepared from proliferating and
quiescent NSCs using three kinds of peptide substrates (Fig. 1a)15.
In comparison with BMP-treated qNSCs, aNSCs exhibited small
increases in the activities of chymotrypsin- and caspase-like
proteases (Fig. 1a), which were completely inhibited by epox-
omicin, a highly specific inhibitor of the proteasome (PI, Fig. 1a).
Notably, qNSCs exhibited much higher trypsin-like activity than
aNSCs and fibroblasts (C3H10T1/2 cells); this activity was not
affected by epoxomicin. Unexpectedly, the trypsin-like activity
was completely inhibited by cathepsin inhibitor I (CI, Fig. 1a),
which is a specific inhibitor of the lysosomal proteases: papain
and cathepsins B, L, and S. This result suggests that lysosomal
activity was elevated in qNSCs. Consistent with this result,
mRNA levels of lysosomal factors including cathepsins (CtsA,
CtsB, and CtsF) and Lamp1, a lysosomal membrane protein,
increased in NSCs upon entry into the quiescent state (Fig. 1b).
Immunostaining of Lamp1 revealed that qNSCs contained more
lysosomes in the cytoplasm than aNSCs (Fig. 1c), which was also
detected in other NSCs, NS5 cells (Fig. 1d), and adult NSCs from
the SVZ and DG (Fig. 1e). Furthermore, cathepsin activity
measured by Magic Red staining was significantly higher in
qNSCs than in aNSCs (Fig. 1c, f). These results suggest that
elevated lysosomal activity might be important for proteolysis in
qNSCs.
Next we investigated the transcription factor TFEB, a master
regulator of lysosomal biogenesis16 in BMP-treated qNSCs. TFEB
was expressed at higher levels after BMP exposure, concomitant
with loss of cyclin D1, a G1/S cyclin (Fig. 1b, g, h). TFEB localized
in the perinuclear region in the cytoplasm in all types of aNSCs,
but increased in abundance and expanded its localization within
qNSCs, in which some dots of TFEB were detected in nuclei
(Fig. 1d, e, arrowheads). Western blotting revealed a decrease in
the abundance of phosphorylated TFEB, an inactive form, and an
increase in the level of active TFEB protein in qNSCs after BMP
exposure (Fig. 1h). Consistent with this observation, monitoring
of TFEB transcriptional activity using a luciferase reporter driven
by the TFEB promoter17 revealed that luciferase expression was
higher in qNSCs than in aNSCs (Fig. 1i). We next examined
autophagic activity, because TFEB is involved in expression of
numerous autophagy genes18. Consistent with this, NSCs
expressed higher levels of LC3-II protein, a key component of
autophagosomes and a marker of autophagy activation, after
BMP exposure (Fig. 1g). Moreover, an LC3 turnover assay
revealed higher levels of LC3-II in qNSCs than in aNSCs, even
after lysosomal inhibition (Supplementary Fig. 1c), indicating that
the increase in LC3-II was due not to reduced lysosomal activity,
but rather to enhanced autophagy in qNSCs19,20. Together, these
results indicate that autophagy/lysosomal degradation is strongly
induced when aNSCs enter the quiescent state under TFEB
activation after BMP exposure in vitro.
Lysosomal inhibition allows qNSCs to proliferate. To evaluate
the role of lysosomal degradation in qNSCs, we inhibited lysoso-
mal function with bafilomycin A (BafA), a specific inhibitor of the
vacuolar-type H(+)-ATPase (V-ATPase), which inhibits lysosomal
enzymes and lysosomal membrane flux by increasing pH21. Long-
term BafA treatment was toxic to NSCs, but upon treatment with a
low concentration (20 nM) for 1 day, qNSCs converted their
morphology from a flat to a bipolar shape, similar to that of aNSCs
(Fig. 2a). We monitored cell proliferation by measuring expression
of Ki-67, a proliferation marker, and incorporation of the thymi-
dine analog EdU over 4 h. qNSCs did not express Ki-67, but
replacement of quiescence medium with the proliferation medium
(PM) containing EGF increased the proportion of Ki-67–positive
cells, as previously reported14 (Fig. 2b). We detected some NSCs
expressing Ki-67 after culture in BafA-containing quiescence
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medium (Fig. 2b, Supplementary Fig. 2a). The percentages of Ki-
67– and EdU-positive cells significantly increased relative to those
in control qNSCs (Fig. 2c). The increase in the proportion of EdU-
positive cells after BafA treatment peaked at 20 nM BafA (Sup-
plementary Fig. 2b). The elevation in the proportion of Ki-
67–positive cells also appeared at a different cell density in the
presence of BafA (Supplementary Fig. 2c).
Next, we analyzed the effects of BafA treatment on the EGF
and Notch pathways, which play essential roles in the activation
of NSCs. In qNSCs, the levels of EGFR, phospho-(P-)EGFR (the
activated form), P-MEK (the activated form of MEK, a down-
stream target of EGFR signaling), and various forms of the
Notch1 receptor (full-length precursor [Notch1 FL], processed
mature form [NTMD], and activated form [NICD]; Supplemen-
tary Fig. 3a) were reduced when aNSCs entered a quiescent state
in quiescence-inducing medium containing BMP (Fig. 1g). On
the other hand, BafA-treated qNSCs continuously expressed P-
EGFR and NICD from 4 h and cyclin D1 from 8 h onward after
BafA treatment, and expressed P-MEK at a higher level for longer
than the control (Fig. 2d, Supplementary Fig. 2d). Although
medium change at time zero induced P-MEK at 4 h and caused a
slight induction of cyclin D1 at 8 h in the control cells (Fig. 2d,
Supplementary Fig. 2d), these inductions were not maintained in
















































































































































































Fig. 1 Increased lysosomal activity in qNSCs in vitro. a Peptidase activities in NSCs. Trypsin-like, chymotrypsin-like, and caspase-like activities in NSC lysate
were continuously measured every 5 min for 1 h, with or without proteasome inhibitor (PI) or cathepsin inhibitor (CI); n= 2. b qPCR of the lysosomal
genes: Lamp1 and cathepsins (CtsA, CtsB, and CtsF), and the transcriptional regulator TFEB, after BMP exposure. c Immunocytochemistry of Lamp1
(red) with DAPI (blue) (upper panels). Staining of Magic Red cathepsin L (red) and Hoechst 33342 (blue) (lower panels). Scale bars, 50 µm. d, e
Immunocytochemistry of Lamp1 and TFEB in the active and quiescent states induced by BMP in NSCs, NS5 cells (d) and adult NSCs (e). Selected regions
indicated by white squares are enlarged. Yellow arrowheads in enlarged squares indicate nuclear localization of TFEB in the quiescent state. Scale bars,
100 µm. f Lysosomal cathepsin L activity in NSCs, as determined using Magid Rred cathepsin L; n= 3. Corresponding data points were plotted.
g Immunoblots of signaling molecules in NSCs after BMP exposure. β-Actin was used as a loading control. h Immunoblotting of several NSC lines in the
active and quiescent states. Phosphorylated (##) and dephosphorylated forms of TFEB (#) were detected. i Reporter assay of TFEB-promoter–driven
luciferase; n= 4. Data represent means ± s.e.m. (**P < 0.01; Student’s t-test). Source data of immunoblots are provided as a Source Data file.
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activation of MEK and cyclin D1 is specific to BafA treatment.
Immunostaining for EGFR revealed that accumulation of
cytoplasmic EGFR, which was not detected in qNSCs, persisted
in BafA-treated cells even in the absence of EGF, as well as in
aNSCs in EGF-containing proliferation medium (Fig. 2e).
Accumulation of P-EGFR and NICD plateaued under treatment
with 20 nM BafA for 4 h (Supplementary Fig. 2e), the same BafA
concentration that was associated with the peak level of EdU-
positive cells (Supplementary Fig. 2b). These data suggest that
BafA induced accumulation of activated EGFR (P-EGFR) and
activated NotchR (NICD), which in turn allowed cell-cycle
reentry of qNSCs. Consistent with this idea, microarray analysis
to monitor mRNA expression at 4 h after BafA treatment revealed
upregulation of genes related to cell proliferation and elevated
receptor activity in BafA-treated cells (Supplementary Fig. 2f).
Expression of Notch and EGF signaling-related genes increased at
4 and 24 h after BafA treatment (Supplementary Data 1 and 2).
To assess the involvement of autophagy, we analyzed SAR405,
a specific inhibitor for VPS34 and autophagosome formation22;
however, SAR405 did not affect the levels of cyclin D1, P-EGFR,
or NICD (Supplementary Fig. 2g). Recent studies demonstrated
that V-ATPase is involved in endocytosis23 as well as endolyso-
somal trafficking24, and that BafA may inhibit the endoplasmic
reticulum (ER) calcium ATPase25. However, inhibitors of
clathrin-mediated endocytosis (Dynasore), the ER calcium
ATPase (thapsigargin [Tg]), and microtubule organization
(nocodazole [Noc]) had weaker effects on cyclin D1 and P-
EGFR than BafA (Supplementary Fig. 2h), and thapsigargin
induced abnormal cleavage of Notch1 receptor. Together, these
results indicate that the lysosomal defect, but not autophagy- or
endocytosis-related defect, is responsible for BafA treatment
induced aberrant increases in the levels of both P-EGFR and
NICD in qNSCs, which are prone to induce cyclin D1 expression
and undergo the cell-cycle reactivation. We also analyzed the
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Fig. 2 Lysosomal inhibition to qNSCs. a Bright field view of NSCs; bipolar proliferating NSCs (aNSC), flat qNSCs (qNSC), and bipolar qNSCs treated with
20 nM bafilomycin A (qNSC, BafA). b Immunocytochemistry of Ki-67. Representative view of NSCs immunostained for Ki-67 (green) and Sox2 (red).
qNSCs were incubated in proliferation medium containing EGF (qNSC, PM), quiescence medium (qNSC), or quiescence medium containing BafA (qNSC,
BafA) for 1 day, and then analyzed. c Percentage of Ki-67–positive (Ki) or EdU-incorporated (EdU) cells. Results are averages of eight samples of qNSCs
(control), BafA-treated qNSCs (BafA), or qNSCs after incubation with proliferation medium (PM); n= 8. d Immunoblotting of qNSCs after incubation with
qNSC medium (control) or qNSC medium containing BafA (20 nM) (BafA) for 4–20 h. e Immunocytochemistry of EGFR. BafA-treated qNSCs accumulated
EGFR (green) in the cytoplasm. EGFR on the cell surface was not detected by immunostaining following membrane permeabilization. This might be
responsible for the differences between the results of immunostainings and western blotting. f Effect of medium change. Samples on the left sides of blots
were incubated in fresh quiescence medium, with or without BafA. In the w/o medium change samples, the medium in culture dishes was partially
removed and added back with or without addition of BafA. Scale bars, 100 µm. Data represent means ± s.e.m. (*****P < 0.0001; Student’s t-test). Source
data of immunoblots are provided as a Source Data file.
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effect of changing the medium. BafA treatment without changing
the medium dramatically decreased the levels of cyclin D1 and P-
EGFR, but did not change the level of NICD (Fig. 2f), suggesting
that both lysosomal inhibition by BafA treatment and EGFR
activation by new medium are crucial for reactivation of qNSCs.
Regulation of EGFR and Notch signaling in qNSCs. To deter-
mine whether activation of both EGFR and Notch signaling is
required to induce qNSC reactivation under BafA treatment, we
treated cells with DAPT, a gamma-secretase inhibitor, to block
Notch signaling, as well as with AG1478, an EGFR tyrosine kinase
inhibitor (Fig. 3a). We monitored cell proliferation by Ki-67 and
cyclin D1 expression following inhibitor treatment, and detected a
significant decrease in the levels of these proliferation markers;
comparable effects were observed upon treatment with DAPT,
AG1478, or the combination of both inhibitors (Fig. 3b–d). These
results indicate that both EGFR and Notch signaling pathways are
indispensable for reactivation of qNSCs after lysosomal inhibition.
Previous in vivo studies revealed that Notch activation is required
for maintenance of the quiescent state of NSCs: proliferating NSCs
and progenitors are transiently upregulated and then exhausted by
inhibition of Notch signaling26, whereas continuous NICD
expression promotes NSC proliferation27. These opposing functions
of Notch might be dependent on expression mode or environ-
mental conditions. In the case of cultured NSCs, Notch signaling
might promote NSC proliferation: NICD was highly upregulated in
proliferating aNSCs (Fig. 1g), and inhibition of Notch prevented the
reactivation of qNSCs after BafA treatment (Fig. 3b–d).
We next investigated how NSCs regulate the stability of these
receptors in the quiescent and proliferating states by measuring
protein stability following treatment with the translational
inhibitor cycloheximide. In the case of BafA-treated samples,
we collected samples 4 h after BafA addition, because longer
incubation with BafA can cause effects independent of lysosomal
inhibition28. The results revealed that activated EGFR (P-EGFR)
was degraded more rapidly in qNSCs than in aNSCs (Fig. 3e).
Removal of EGF from the culture medium of aNSCs did not
significantly alter the rate of degradation (Fig. 3e). BafA
dramatically stabilized P-EGFR in qNSCs (Fig. 3e), although
the level of P-EGFR was lower in qNSCs than in aNSCs
(Supplementary Fig. 2i, j). Total EGFR was degraded more
rapidly in aNSCs in the presence of EGF than in qNSCs (Fig. 3e).
Together, these results lead to several conclusions. First, overall
degradation of EGFR is limited in the absence of EGF; second,
consequently, EGFR is activatable even in qNSCs at a low level
(mathematically simulated in Supplementary Notes). Third,
activated EGFR in qNSCs is rapidly degraded via the lysosomal
degradation pathway.
Next, we examined the protein stability of Notch1 receptor,
and found that NICD was degraded at the same rate in
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Fig. 3 Regulation of EGF and Notch signaling in qNSCs with defects in lysosomal function. a Cells were incubated for the indicated times with inhibitors of
Notch (DAPT) and EGF signaling (AG1478) after BafA treatment at t= 0 h. qNSCs were cultured with 10 µM DAPT from t= 12 h (arrow), 5 µM AG1478
from t= 22 h (arrow), or both inhibitors in the presence of 20 nM BafA, and then analyzed at t= 24 h (arrowhead). DAPT required a longer incubation
time than AG1478 to reduce the NICD level. b Percentage of Ki-67–positive cells in Sox2-positive cells. c Representative immunoblots of qNSCs after
incubation with inhibitors in the presence of BafA. d Relative protein levels of P-EGFR, NICD, and CycD1 in (c), normalized against β-actin. e Protein stability
of EGFR (n= 2). BafA was added 4 h before all assays in lysosomal-inhibited samples. Activated EGFR (P-EGFR) and total EGFR (EGFR) in immunoblots
were quantified and plotted (lower panels). Left panel: qNSCs degrade P-EGFR (red closed circles) more rapidly than aNSCs (blue closed squares), but the
protein was stabilized in the presence of BafA (red open circles). Total EGFR degradation depended on the presence of EGF (blue squares). Data represent
means ± s.e.m. (*P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001, ***** P < 0.0001; Student’s t-test). Source data of immunoblots are provided as a Source
Data file.
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proliferating and quiescent NSCs (Supplementary Fig. 3b).
Mature (NTMD) and full-length Notch1 receptors were degraded
at similar rates in aNSCs and qNSCs (Supplementary Fig. 3c, d).
BafA completely stabilized both NICD and NTMD but did not
affect the cleavage of full-length Notch1 (Supplementary
Fig. 3b–d). These results demonstrate that lysosomal inhibition
stabilizes membrane-anchored NTMD, potentially resulting in
the abnormal increase of NICD in BafA-treated cells.
Enhanced lysosomes maintain qNSCs in brain. We next tried to
address lysosomal functions in NSCs in the juvenile and adult
mouse brain. We monitored in vivo expression of the lysosomal
proteins cathepsin B, cathepsin L, and Lamp1 by immunohis-
tochemistry of the DG and the SVZ of the lateral ventricle. To
identify NSCs in brain tissues, we used GFAP-GFP;Nestin-NLS-
mCherry double-transgenic mice29–32. In this transgenic mouse
line, NSCs were labeled with GFP and nuclear-localized mCherry
signals expressed under the control of mouse GFAP and Nestin
promoters, respectively, and aNSCs were distinguished by Ki-67
staining. We compared the immunostaining of lysosomal
enzymes between qNSCs and aNSCs in the DG and SVZ in young
and adult mice (2-week-old and 6-month-old). Cathepsins and
Lamp1 were stained as cytoplasmic dots in both types of NSCs.
The dots were more dense and abundant in qNSCs (arrowheads)
than in aNSCs (arrows) in both the DG and SVZ of 2-week-old
mice (Fig. 4a, Supplementary Fig. 4a–d). In 6-month-old mice,
the morphology of qNSCs in the DG was different from that in 2-
week-old mice, but lysosomes were distributed similarly to those
in young mice and condensed in qNSCs (Supplementary Fig. 4e),
especially in the basal region of long processes of qNSCs at both
ages (Fig. 4a, Supplementary Fig. 4a–c, e). Lysosomes were sig-
nificantly more abundant in qNSCs than in aNSCs (Fig. 4b).
These observations are consistent with our data obtained in vitro
(Fig. 1c–f).
Acute BafA injection into the DG of mouse brain resulted in
severe lysosomal damage around the injected regions. Therefore,
in order to analyze the effect of lysosomal inhibition by BafA in
the brain tissue, we pursued ex vivo approach using slice cultures
of GFAP-GFP;Nestin-NLS-mCherry double-transgenic mice.
Slices, including the whole DG from individual hemispheres,
were incubated in BafA-containing or control culture medium for
15 h (Fig. 4c). Total NSCs (GFP+ mCherry+ [double-positive]
cells) and aNSCs (GFP+ mCherry+ Ki-67+ [triple-positive] cells)
were counted in the SGZ of all brain slices (Fig. 4d). For
quantitative analyses, we eliminated cells with sparse GFP
expression, which might include GFAP-negative intermediate
progenitors, reported previously33. BafA-treated slices contained
significantly higher numbers of aNSCs than controls (Fig. 4e).
BafA treatment did not affect the total number of NSCs over the
course of the experimental period (Fig. 4f), but it did significantly
increase the proportion of aNSCs in total NSCs relative to the
control (Fig. 4g). Culturing slices upregulated genes associated
with acute injury responses, but this effect was comparable
between control and BafA-treated slices after culture (Supple-
mentary Fig. 4f). These results indicate that lysosomes are
enriched in qNSCs in vivo as well as in vitro, and that inhibition
of lysosomal function can reactivate NSCs in the SGZ.
Role of lysosomal enhancement by TFEB activation in NSCs.
To investigate the role of lysosomal activation in NSC prolifera-
tion, we activated lysosomes by two methods: first, pharmacolo-
gically, and second, with constitutively active mutants of TFEB.
TFEB is inactivated by phosphorylation mediated by target of
rapamycin complex 1 (mTORC1), a conserved serine/threonine
kinase complex34. We analyzed cell proliferation after treatment
with the mTORC1 inhibitors rapamycin and Torin-1. Phos-
phorylated TFEB, the inactive form, disappeared by 4 h (Fig. 5a,
lanes 5 and 8), and the levels of cyclin D1 were reduced by
incubation with the inhibitors (Fig. 5a, lanes 6–10, and Fig. 5b).
mTORC1 is involved in downstream EGF signaling in neural
progenitor cells35,36. To verify the involvement of TFEB in cell
proliferation, we analyzed phospho-deficient mutants of TFEB,
TFEB S141A (mt1), and TFEB S210A (mt2), which are con-
stitutively active. Ser141 and Ser210 in mouse TFEB are con-
served residues previously identified as mTORC1 targets34. The
mutants, as well as wild-type TFEB, were expressed as GFP
fusions. We first continuously expressed these mutants under the
control of the EF promoter in a construct delivered by a lentiviral
vector, but the number of mutant TFEB-GFP–expressing cells
was dramatically decreased in culture after several passages. Thus,
these TFEB-GFPs were expressed under the control of a dox-
ycycline (dox)-inducible promoter after transduction with lenti-
viral vectors (Fig. 5c–e, Supplementary Fig. 5). TFEB S141A and
S210A mutants localized in the nucleus to greater extent than
wild-type TFEB (Fig. 5c) as reported previously34. Expression
levels of mutant TFEB-GFPs were comparable to those of wild-
type TFEB-GFP and endogenous TFEB on 1 day (Fig. 5d, lanes
4–6), but gradually decreased relative to the wild type on days 2
and 3 (Fig. 5d, lanes 7–12). This result suggests that the number
of cells expressing mutant TFEB-GFPs relative to that of non-
infected cells decreased in culture, similar to the observation
using the EF promoter as mentioned above. Consistent with this
observation, the proportion of TFEB-GFP–expressing cells that
were Ki-67–positive decreased in TFEB mutants (Fig. 5e). Live-
cell imaging confirmed significant decreases in cell division in
NSCs expressing the TFEB S210A mutant (Supplementary
Fig. 5a, b, Supplementary Movies 1 and 2). These results indicate
that TFEB activation decreases NSC proliferation in vitro.
To activate lysosomes via TFEB activation in NSCs of the adult
brain, we stereotactically injected lentiviral vectors encoding wild
type and constitutively active mutant (S210A) TFEB (wtTFEB
and caTFEB, respectively) under the control of the Hes5 and Gfap
promoters into the DG of the adult mouse brain37 (Fig. 5f–h).
Both promoters enabled expression of TFEB-GFP in the SGZ
(Fig. 5g). NSCs expressing TFEB-GFP were identified as GFAP-,
GFP-, and Sox2-triple–positive cells in the SGZ; TFEB-
GFP–positive aNSCs were identified as GFAP-, GFP-, Ki-67–,
and Sox2-quadruple–positive cells (Fig. 5g). caTFEB significantly
decreased the number of Ki-67–positive aNSCs in the DG
(Fig. 5h). These observations indicate that TFEB activation
decreases proliferation and induces quiescence in NSCs of the
SGZ in the adult brain.
TFEB-knockout increases the abundance of active NSCs. To
confirm the role of TFEB in qNSCs in vitro, we deleted the Tfeb
gene in NSCs derived from Tfeb-flox mice34. For this purpose, we
used the Rosa-CAG–based tdTomato reporter line (Ai14), in
which NSCs and their progeny are labeled with tdTomato fol-
lowing Cre excision. We generated NSCs from embryos after
crossing Tfeb(flox/flox) and Tfeb(flox/+);Ai14(+/+) mice,
yielding heterozygote [Tfeb(flox/+);Ai14] and homozygote [Tfeb
(flox/flox);Ai14] NSCs. The Tfeb-flox gene was excised by tran-
sient Cre expression under control of the CAG promoter, intro-
duced by lipofection, and then tdTomato-positive cells from
homozygotes (HOMO) and heterozygotes (HET) (used as a
control) were purified by cell sorting. These cells were cultured in
quiescence-inducing medium to analyze the effect of Tfeb-
knockout (KO) on the quiescent state. TFEB protein was clearly
depleted in Tfeb-KO NSCs (HOMO) relative to the parental cells
(Fig. 6a, lanes 3 and 4) and control NSCs (HET) (Fig. 6a, lanes 2
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Fig. 4 Increased lysosome abundance in quiescent NSCs and lysosomal inhibition in the tissue. a Immunohistochemistry of cathepsin L in the DG of GFAP-
GFP;Nestin-NLS-mCherry mice. Proliferating NSCs expressed Ki-67 (gray), GFP (green), and mCherry (blue), but qNSCs were Ki-67–negative. The
selected region indicated by a white square is enlarged below. Proliferating NSCs (arrows) exhibited lower cathepsin L (CtsL) staining than qNSCs
(arrowheads). Cell shapes are indicated by gray lines in the lower panel. b Quantified values of cathepsin L intensity in individual NSCs in the DG (n= 32 in
total). c Experimental design of brain slice cultures. d Representative images of the DG stained with DAPI (blue), GFP (green), mCherry (red), and Ki (gray)
at a single plane of the brain slices after the slice culture. Open and closed arrowheads indicate qNSCs and aNSCs, respectively. e, f Numbers of Ki-67, GFP,
and mCherry triple-positive cells (aNSCs (e)), and GFP and mCherry double-positive cells (NSCs (f)) in the SGZ of brain slices from 6-month-old mice
cultured with DMSO (vehicle) or BafA. Dot plots show the sums of numbers of aNSCs (e) and NSCs (f) in individual hemispheres. Average values in each
data set are shown by cross bars, and dotted lines link results from the same individuals. g Box plot showing the proportion of aNSCs in NSCs (center line,
median; box limits, upper and lower quartiles; whiskers, minimum and maximum). Corresponding data points was plotted as dots. BafA increased the
proportion of aNSCs to total NSCs in the DG. Scale bars, 50 µm. Data represent means ± s.e.m. (*P < 0.05; n.s., not significant; Student’s t-test, n= 10
for e–g).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13203-4 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:5446 | https://doi.org/10.1038/s41467-019-13203-4 | www.nature.com/naturecommunications 7
and 4, and Fig. 6b). Tfeb-KO NSCs stained with LysoTracker
exhibited weaker signals than the parental control (Fig. 6c),
indicating that Tfeb-KO reduced lysosomes in qNSCs. Expression
of multiple lysosomal genes was significantly reduced in Tfeb-KO
NSCs (Fig. 6d). Tfeb-KO increased the number of Ki-67–positive
NSCs compared to the control after the quiescence induction
(Fig. 6e, f), indicating that Tfeb-KO NSCs entered quiescence
more slowly than the control. Consistent with this, active forms of
EGFR and Notch1, which accumulated upon lysosomal inhibition
by BafA in qNSCs (Fig. 2d), were present at higher levels in Tfeb-
KO NSCs than in controls (Fig. 6g, h). These increases in the
levels of P-EGFR and NICD in Tfeb-KO were abolished by
inhibitors of EGFR and Notch, respectively (Fig. 6i, j). These
results indicate that the reduction in lysosomal activity due to
Tfeb deletion exhibited slower adaptation of NSCs to be quiescent
in vitro.
Next, we investigated the conditional knockout of Tfeb (Tfeb
cKO) in vivo using GLAST-Cre-ERT2 mice to induce Tfeb deletion
specifically in adult NSCs after tamoxifen administration38,39. We
injected tamoxifen into 8-week-old mice and analyzed tdTomato-
positive cells in the DG of Tfeb-cKO and the control mice on day
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Fig. 5 Effects of activated lysosomes on aNSC proliferation. a Pharmacological activation of lysosomes in aNSCs. Representative immunoblots for TFEB,
cyclin D1, and actin after incubation with DMSO (Ctrl), 1 nM Torin-1 (Torin), or 10 µM rapamycin (Rap) for 0, 4, 8, or 12 h. b Quantification of cyclin
D1 shown in a. c Immunocytochemistory of TFEB-GFP (green) in the wild type or cells expressing two constitutive-active mutants (mt1: S141A; mt2: S210A)
with DAPI (blue) under the control of the tet-on inducible system on 1 day. White arrowheads indicate nuclear localization of TFEB-GFP. d Representative
immunoblots for GFP, TFEB, and actin in the presence or absence of doxycycline (dox). e Proportions of Ki-67–positive cells in TFEB-GFP–expressing cells
on 1 day and 3 day. Values are shown relative to wild-type TFEB-GFP. Scale bars, 10 µm. Data represent means ± s.e.m. (*P < 0.05 and **P < 0.01; Student’s
t-test for b and e). f Schematic diagram of the delivery of lentiviral vectors encoding TFEB-GFP driven by the Hes5 or GFAP promoter into the DG.
g Representative images from 50-µm-thick FF-IHC sections. Mice were fixed 3 days after virus injection. For counting, every sixth slice through the whole
DG was immunostained with GFAP, GFP, Ki-67, and Sox2 antibodies. h Percentages of Ki-67+ aNSCs among total GFP+ NSCs (box plot: center line,
median; box limits, upper and lower quartiles; whiskers, minimum and maximum). Corresponding data points were plotted as open diamonds. Cells were
counted in the SGZ of around six slices for each condition per mouse, using the Imaris software. Data represent means ± s.e.m. (*P < 0.05; Tukey’s test.
n= 5). Source data of immunoblots are provided as a Source Data file.
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Fig. 6 Reduction in lysosomal activity and slow induction of quiescence by Tfeb-knockout. a Immunoblot of TFEB in Tfeb-KO NSCs (HOMO) and control
NSCs (HET) in the quiescent state in vitro. The parental cells (without Cre excision) and tdTomato-positive cells (purified by cell sorting after Cre excision)
were analyzed after culture in quiescence medium. b Immunocytochemistry of TFEB (green) in Tfeb-KO qNSCs and control qNSCs. Cre-excised cells were
labeled with tdTomato (red). c Bright field and LysoTracker-green staining in Tfeb-KO and parental control NSCs in the quiescent state. dmRNA expression
of lysosomal genes in Tfeb-KO NSCs (gray bars) and controls (white bars) in the quiescent state (n= 4). e Representative immunostaining 3 days after
BMP exposure. f Proliferation of Tfeb-KO (gray bars) and control NSCs (white bars) in quiescence medium. Cells were fixed, stained with Sox2 (blue) and
Ki-67 (green) at 1 and 3 days following BMP exposure, and analyzed (n= 12). g Representative immunoblot for EGFR, Notch1, and their active forms in
Tfeb-KO and control in proliferation medium (aNSC) and on 1 and 3 days in quiescence medium. h Relative quantification of P-EGFR, EGFR, NICD, and
Notch1 on 1 day after BMP exposure in g (n= 4). i Representative immunoblots after incubation with Notch (DAPT) and EGFR inhibitors (AG1478) on
1 day after BMP exposure. Inhibitors were incubated same as Fig. 3a. j Relative quantification of P-EGFR and NICD in i (n= 2, 4). Data represent means ± s.
e.m. (*P < 0.05, ***P < 0.005, ****P < 0.001, *****P < 0.0001; Student’s t-test for d and f, Tukey’s test for h and j, n.s. not significant). Scale bars, 20 µm.
Source data of immunoblots are provided as a Source Data file.
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SGZ of Tfeb-cKO mice, TFEB was depleted in tdTomato-positive
cells after tamoxifen administration. In brain slices throughout the
DG along the rostrocaudal axis, we identified tdTomato-positive
NSCs in the 3D reconstitution by immunostaining for Sox2 and
GFAP. To monitor proliferating cells, proliferating NSCs were
labeled by BrdU for 2 h before fixation, and then counted in brain
slices in wild type (WT), heterozygote (HET), and homozygote
mice (HOMO) on day 6 or at 4 weeks (Fig. 7b). BrdU-labeled
aNSCs were significantly higher in Tfeb-cKO HOMO than in
controls on day 6 (Fig. 7c). HET mice, as well as Tfeb-cKO HOMO
mice, had more aNSCs than wild type at 4 weeks (Fig. 7d),
suggesting that reduced TFEB amount might gradually affect NSC
activation between day 6 and 4 weeks in vivo. At 12 weeks after
tamoxifen administration, both NSCs and aNSCs, identified as Ki-
positive NSCs, were significantly more abundant in Tfeb-cKO
HOMO mice than in control HET mice (Fig. 7f, g, h, i).
Importantly, among all NSCs, Tfeb-cKO HOMO mice had a
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control HET mice (Fig. 7j, k). To determine whether TFEB
depletion in NSCs increased the number of newly generated
neurons, we counted tdTomato and DCX double-positive cells in
the DG (Fig. 7l). However, DCX-positive cells were comparably
abundant in Tfeb-cKO HOMO and control HET mice (Fig. 7n),
suggesting that activation of NSCs did not increase neurogenesis in
Tfeb-cKO mice. The proportion of DCX-positive cells to NSCs was
significantly lower in cKO HOMO mice than in control HET mice
(Fig. 7m). Cells positive for cleaved-caspase-3, a marker of
apoptosis, were scarce in all samples (Fig. 7o). Consistent with
this in vivo result, neuronal differentiation of Tfeb-KO HOMO
NSCs was slightly delayed in vitro (Supplementary Fig. 6a, b).
During differentiation, nuclear localization of TFEB was detected
after 1 day of culture in differentiation medium (Supplementary
Fig. 6c), implying another role of TFEB in the early neuronal
differentiation of NSCs. To analyze the effect of membrane
receptor after TFEB depletion in vivo, we assessed the levels of the
Notch1 receptor by immunostaining (Supplementary Fig. 7a–c).
Levels of the Notch1 receptor were slightly elevated in the SGZ of
adult Tfeb-cKO mice; however, there was a wide variety relative to
wild type (Supplementary Fig. 7c). Alternatively, we analyzed
postnatal Tfeb-cKO mice at P0 stage (Supplementary Fig. 7d, e, see
Methods). In P0 mice, levels of the Notch1 protein intensity
significantly increased in the DG of Tfeb-cKO mice than in wild-
type mice (Supplementary Fig. 7f). To address the expression
profiles of Notch1 and EGFR, we examined these receptors of the
DG in Tfeb-cKO and the control adult mice by western blotting.
The results revealed significant increases in the active forms of
EGFR and Notch1 in Tfeb-cKO mice relative to control mice
(Supplementary Fig. 8a, b). Taken together, our results show that
the reduction in lysosomal activity due to TFEB depletion increases
activation of NSCs in the DG along with accumulation of activated
membrane receptors, resulting in an increase in the number of
aNSCs, but does not enhance their differentiation.
Discussion
Our findings demonstrate that lysosomal activity is higher in
qNSCs than in aNSCs, and that lysosomal inhibition by both
chemical and genetic approaches increases the proportion of
aNSCs among all NSCs both in the DG of mouse brain, as well as
in cultured qNSCs with higher levels of membrane receptors
(Supplementary Fig. 9). These results suggest that enhanced
lysosomal function is important for adaptation and maintenance
of qNSCs in the adult mouse brain. Given that activated EGFR
was rapidly degraded in qNSCs in vitro, enrichment of lysosomes
might serve to increase the chance that endosomal vesicles con-
taining membrane receptors will fuse to lysosomes, thereby
reducing the time required for signal transduction from the
endosome via endolysosomal fusion. Other regulatory events,
such as the initiation of endocytosis, endosomal traffic, and
recycling, may also contribute to the selective reduction of acti-
vated EGFR in qNSCs. EGFR expression persisted at low levels in
qNSCs14,40, potentially enabling these cells to remain in a poised
state capable of responding to activation signals. On the other
hand, degradation of Notch1 receptor was similar in qNSCs and
aNSCs, implying that the degradation rate of Notch receptor is
independent of the enhanced lysosomal activity in NSCs. Med-
ium change was another crucial inducer of qNSCs reactivation,
suggesting that cooperative functions of BafA and a factor in fresh
medium are required for qNSC reactivation in vitro. Because the
levels of phosphorylated FGF receptor 1 (FGFR1), as well as P-
EGFR, increased by BafA in new quiescent medium, FGF is a
strong candidate for such a factor.
In addition, we detected TFEB activation in qNSCs (Supple-
mentary Fig. 9). Tfeb gene has been identified as a downstream
targets of p-SMAD1/5 in the BMP signaling pathway in hair
follicle stem cells41, implying that BMP signaling might directly
activate TFEB transcription. In this study, we observed that TFEB
protein was dephosphorylated after BMP exposure in adult NSCs,
suggesting that post-translational regulation of TFEB, such as
dephosphorylation by inhibition of mTOR complex 1 (mTORC1),
might lead to TFEB activation in qNSCs34. Once activated, TFEB
can increase transcription of TFEB itself via an auto-regulatory
loop, as well as the expression of most lysosomal genes under the
coordinated lysosomal expression and regulation (CLEAR) gene
network. This idea is consistent with our findings that TFEB
activation by chemical activatiors and consitiutively active
mutants prevented aNSC proliferation in vitro (Fig. 5a–e).
Regarding cell differentiation, roles of the microphthalmia family
(MiTF, TFEB, TFE3, and TFEC) of transcription factors have been
reported for TFEB in osteoclast differentiation42 and TFE3 in
macrophage differentiation43. Recent studies also showed that
TFE3, like TFEB, regulates lysosomal gene expression44, suggest-
ing that TFE3 might cooperate in maintenance of qNSCs. For
quality control in NSCs, autophagy might contribute to removal of
abnormal compartments such as damaged protein aggregates and
mitochondria, which are sources of oxidative stresses; this has
been reported in mice harboring a conditional knockout of the
autophagy-related gene FIP200 under the control of the hGFAP-
Cre driver45,46. After reactivation of qNSCs, the abundant lyso-
somes might be diluted after cell division or secreted along with
their lysosomal contents to the cell surface, thereby inducing
environmental changes that further contribute to NSC activation.
Our results obtained from Tfeb-KO NSCs in vitro revealed that
aNSCs exhibited slower induction of the quiescent state than the
control (Fig. 6), and that Tfeb deletion in NSCs increased the
number of aNSCs in the DG in vivo (Fig. 7). These results
indicate that reduced lysosomal activity increases the abundance
Fig. 7 Elevated number of proliferating NSCs in the SGZ of Tfeb-cKO mice. a aNSCs in Tfeb-cKO mice and control mice were labeled with BrdU for 2 h
before fixation on day 6 or at 4 weeks (4W) after tamoxifen administration. b Representative images of the DG in wild type (WT) and cKO mice (HOMO)
at 4 weeks, immunostained with GFAP (blue), BrdU (green), tdTomat (red), and Sox2 (gray). c, d Dot plots showing the number of BrdU-positive aNSCs in
the DG of wild type (WT), heterozygote (HET), and homozygote Tfeb-cKO (HOMO) mice. Cells were counted in each image from 50-µm-thick FF-IHC
sections throughout the DG. Four and six slices from each brain were counted on day 6 (c) and at 4 weeks (d), respectively (n= 4 [WT], 3 [HET], and 3
[HOMO] for day 6; n= 3 [WT], 2 [HET], and 3 [HOMO] for 4 weeks). e Tfeb-cKO mice (HOMO) and control mice (HET) were analyzed 12 weeks after
tamoxifen administration. f Representative images of the DG from the control (HET) and Tfeb-cKO mice (HOMO), immunostained for GFAP (blue), Ki-67
(green), and Sox2 (gray) and processed using the Imaris software (right panels). Processed images were used to count NSCs (magenta spots) and aNSCs
(green spots) using the Imaris software. g Enlarged view of white squares in f. h, i Dot plots showing the numbers of total NSCs and aNSCs in slices. Six
slices from each brain were counted (n= 4 [HET] and 3 [HOMO]). j, k Proportions of aNSCs to NSCs (j) and qNSCs to NSCs (k), calculated from (h) and
(i). l Representative images of the DG, immunostained as indicated (left panels) and processed (right panels) to count DCX-positive cells (green spots)
and NSCs (magenta spots). m Ratio of DCX-positive cells to NSCs. Six slices from each brain were counted (n= 2 [HET] and 3 [HOMO]). n, o Average
number of cells double-positive for tdTomato and DCX (n) or tdTomato and cleaved-caspase-3 (o) in the DG in slices. Data represent means ± s.e.m. (*P <
0.05, **P < 0.01, ****P < 0.001, *****P < 0.0001; Student’s t-test). Scale bars, 200 µm.
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of aNSCs in vitro and in vivo. Especially, in vivo, the increases in
the abundance of aNSCs due to TFEB depletion might progress
slowly, along with some unknown compensation machinery in
qNSCs. On the other hand, given that the ratio of DCX-positive
cells to NSCs was reduced in Tfeb-cKO mice in vivo and Tfeb-KO
NSCs in vitro, TFEB might also be involved in differentiation
from NSCs. Further analyses of different time periods following
Tfeb deletion from the embryonic stage or earlier adulthood
might reveal the role of lysosomes in NSC differentiation and
brain formation. Moreover, samples from the later time period,
after Tfeb deletion, could reveal the role of lysosome in aged
brain. Together, our findings demonstrate that lysosomal func-
tion contributes to maintenance of NSC quiescence.
Methods
Mice. Tfeb-flox mice34 were crossed with Ai14 reporter mice (Rosa-CAG-LSL-
tdTomato-WPRE, stock 007908, The Jackson Laboratory) or GLAST-CreERT2
mice (a kind gift from M. Götz38,39, and the offspring were crossed to obtain
GLAST-CreERT2;Ai14;Tfeb(flox/flox), GLAST-CreERT2;Ai14;Tfeb(flox/+) and
GLAST-CreERT2;Ai14 mice. Two milligrams tamoxifen (Tam; Sigma, 20mg/ml in
corn oil) was intraperitoneally injected into adult mice (8-week-old) by twice
injections a day (or once injection a day for BrdU experiments) for five consecutive
days to induce Tfeb deletion and tdTomato expression. Tam-injected mice were
housed in individual cages and sacrificed at the times indicated in each experiment.
For the BrdU incorporation assay, 200mg/kg BrdU (BrdU; Sigma, 10mg/ml in a
saline solution) was intraperitoneally injected 2 h before fixation. GFAP-GFP;Nes-
tin-NLS-mCherry double-transgenic mice were obtained by crossing GFAP-GFP
reporter mice29 with Nestin-NLS-mCherry mice32. Nestin-CreERT2 mice47 were
crossed with Tfeb-flox mice (Supplementary Methods). All mice were of the C57BL/
6 background. Mice were maintained in our animal facility and housed in a 12:12
hour light–dark cycle. Animal care and experiments were conducted in accordance
with the guidelines of the animal experiment committee of Kyoto University. We
have complied with all relevant ethical regulations for animal testing and research.
Cell culture and induction of quiescent state. C3H10T1/2 mouse fibroblast
cells (ATCC) were grown in Dulbecco’s modified Eagle’s medium (DMEM;
Nacalai Tesque) supplemented with 10% fetal bovine serum (FBS) and
penicillin–streptomycin (P/S; Nacalai Tesque)48. NSCs were passaged in proliferation
medium [20 ng/ml EGF (Wako), 20 ng/ml bFGF (Wako), P/S, and N-2 Plus media
supplement (R&D Systems) in DMEM/F-12 (Gibco)] with the addition of 2 µg/ml
laminin (Wako)13,14. We used cultured NSCs passaged about 10 times and frozen
several times after dissociation from the ventral telencephalon of ICR mouse embryos
at E14.5 (ref. 13). This NSC line expressing Nestin as well as Sox2 was clearly induced
to enter quiescence after BMP exposure and induced back to active state after BMP
withdrawal, as in the NS5 cell line (a kind gift from A. Smith49; Supplementary
Fig. 1a, b). Adult NSCs were derived from the SVZ and DG of 7-week-old C57BL/6
mice. The DG and SVZ were surgically isolated from the three mice, dissociated by
enzymes, purified in 20% Percoll by centrifugation, and cultured as adherent primary
cell cultures in proliferation medium [20 ng/ml EGF, 20 ng/ml bFGF, P/S,
B27 supplement (Gibco), 1× Glutamax (Gibco), 2 mg/ml heparin in Neurobasal
medium (Gibco)]50. To induce quiescence, we plated 1 × 106 cells in six-well dishes or
2 × 105 cells (or 1 × 105 cells only for Supplementary Fig. 2c) in 24-well dishes. The
next day, we replaced the proliferation medium with quiescence medium [50 ng/ml
BMP4 (R&D Systems) in medium of the same composition as proliferation medium
except lacking EGF] after three washes with phosphate-buffered saline (PBS), and
then cultured the NSCs in quiescence medium for 3 days14.
Preparation of Tfeb-KO NSCs. Tfeb(flox/flox) and Tfeb(flox/+);Ai14 mice were
crossed, and embryos were harvested at E14.5. After dissociation from the ventral
telencephalon, cells were seeded on poly-L-ornithine (Sigma)– and fibronectin
(R&D Systems)-coated dishes, and then cultured in proliferation medium as
described in the Cell Culture section. To delete the floxed sequences in vitro,
pCAG-Cre was transiently transfected by lipofection using ViaFect (Promega), and
tdTomato-positive cells were sorted using a FACS AriaII SORP (BD).
Proliferation assays and inhibitor treatments to NSCs. To monitor NSC pro-
liferation, we analyzed NSCs by immunostaining of mouse anti–Ki-67 antibody
(BD Pharmingen) and Click-IT EdU detection (Invitrogen) after 4 h exposure to
EdU, and co-stained with rabbit anti-Sox2 antibody (EMD Millipore) or DAPI
(Sigma) to count all cells. Cell images were obtained on AF6000 (Leica) and BZ-X
(Keyence). Cell counting was performed using the ImageJ software for images
captured on the AF6000, and Hybrid cell count (Keyence), an algorithm for cell
counting, for images captured on the BZ-X. Six to eight images were collected
under each condition. Inhibitors used for cell culture were obtained from the
indicated suppliers: bafilomycin A1 (Sigma), SAR405 (Cayman Chemical), Dyna-
sore (Adipogen), thapsigargin (Adipogen), nocodazole (Adipogen), DAPT
(Calbiochem), AG1478 (Cell Signaling Technology), Torin-1 (Cayman Chemical),
and rapamycin (Wako). To measure protein stability, cells were incubated with 10
µg/ml cycloheximide (Sigma) to block protein synthesis.
Measurement of proteasomal and lysosomal activity. For measurement of 26S
proteasome activities 9,15, cell lysate was extracted in proteasome activity assay buffer
(50mM Tris-HCl [pH 7.5], 250mM sucrose, 5 mM MgCl2, 0.5mM EDTA, 2mM
ATP, 1mM DTT). Six micrograms of total protein extract was transferred to a 96-
well plate, and substrate was added. The fluorogenic substrates Suc-Leu-Leu-Val-Tyr-
MCA (Peptide Institute), Boc-Leu-Arg-Arg-MCA (Peptide Institute), and Ac-Nle-
Pro-Nle-Asp-AMC (Enzo), all at 100 µM working concentration, were used to
measure the chymotrypsin-like, trypsin-like, and caspase-like activities of the pro-
teasome, respectively. Fluorescence was monitored every 5min for 1 h at 37 °C on an
ARVO X3 microplate reader (PerkinElmer) using a 355-nm excitation filter and a
460-nm emission filter. Protein concentration was determined using the DC protein
assay (Bio-Rad). Inhibitors specific for the proteasome and cathepsins were epox-
omicin (Peptide Institute) and cathepsin inhibitor I (Calbiochem), respectively, both
used at a working concentration of 20 µM. Measurement of lysosomal cathepsin
activity was performed by using a Magic Red cathepsin L assay kit (Immunochem-
istry). NSCs were incubated with a substrate to visualize lysosome activity in living
cells for 30min and then incubated with Hoechst 33342 for 5 min according to the
manufacture’s instructions. Cells were fixed with 4% PFA and observed on an AF6000
microscope. Image intensities were analyzed using the ImageJ software.
Luciferase reporter assay. The reporter plasmid encoding TFEB-
promoter–driven luciferase was transfected into aNSCs with pCMV-Renilla to
normalize transfection efficiency. Transfected NSCs were cultured in quiescent or
proliferation medium for 3 days, and then analyzed using the PicaGene Dual Sea
Pansy Luminescence Kit (Toyo Ink). The TFEB-promoter–driven luciferase
reporter was a gift from Albert La Spada (Addgene plasmid # 66801).
Plasmids and lentivirus for TFEB mutants. Mouse Tfeb (NM_001161722) was
cloned from cDNA of mouse ES cells and subcloned into pCW57.1, a gift from David
Root (Addgene plasmid #41393) after fusion of GFP to the C-terminal end of TFEB
and site-directed mutagenesis to generate the constitutive-active mutants S141A and
S210A. Ser141 and Ser210 were identified as phosphorylation sites in mouse TFEB
based on sequence conservation with human TFEB. Lentiviral particles were pro-
duced by co-transfection with the packaging plasmids51 into Hek 293T cells, con-
centrated by centrifugation of the supernatants, and transducted into NSCs.
Transducted NSCs were established after selection in 0.5 µg/ml puromycin, and then
cultured in 3 µg/ml doxycycline to induce expression of TFEB-GFP.
Lentivirus injection into the DG. For specific expression in NSCs in vivo, the
mouse Gfap promoter29 or Hes5 promoter37 was subcloned into vector CSII51.
Lentiviral particles were produced in HEK 293T cells cultured in OptiPRO serum-
free medium (Gibco) and concentrated by centrifugation after washing with PBS.
Viruses were delivered stereotactically into the DG of 6-week-old C57BL/6 male
mice using the following coordinates: 1.9 mm posterior to bregma, 1.4 mm lateral
to the midline, and 1.75 mm below the dura.
Western blot and qPCR. For western blotting, cells were lysed in lysis buffer
(50mM Tris-HCl [pH 8.0], 100mM NaCl, 5 mM MgCl2, 0.5% Nonidet P-40,
Complete™ protease inhibitor cocktail (Roche), 1 mM phenylmethylsulfonyl fluor-
ide, 250 U/ml Benzonase (Sigma), 10mM β-glycerophosphate, 1 mM sodium
orthovanadate, 1 mM NaF, and 1 mM sodium pyrophosphate) on ice for 30min,
and then boiled after the addition of 1% SDS. Protein concentration of total cell
lysate was measured by the DC protein assay, and 20 µg protein from each sample
was loaded for SDS-PAGE. Western blots were visualized by chemiluminescence
using Amersham ECL (GE) or ECL prime (GE), quantified on an LAS3000 image
analyzer (Fujifilm), and normalized against the corresponding intensity of β-actin.
The following primary antibodies were used for western blotting: rabbit anti-actin
(Sigma), mouse anti-cyclin D1 (A-12; Santa Cruz Biotechnology), rabbit anti-EGFR
(EMD Millipore), rabbit anti-phospho-EGF receptor (Tyr1068; Cell Signaling
Technology), rabbit anti-Hes1 (ref. 48), rabbit anti-LC3 (Wako), rabbit anti-phos-
pho-MEK1/2 (Ser221; Cell Signaling Technology), rabbit anti-cleaved Notch1
(Val1744; Cell Signaling Technology; to detect only activated Notch [NICD]),
mouse anti-Notch1 (C-term, Novus; to detect all Notch1 protein, including full-
length, NTMD, NEXT, and NICD), rabbit anti-Sox2, and rabbit anti-TFEB (Bethyl
Laboratories). Secondary antibodies were HRP-conjugated anti-mouse and anti-
rabbit antibodies (GE Healthcare). Western blots accompanied with molecular
weight markers were provided as Source Data Files. For qPCR, total RNA was
extracted using the RNeasy Plus mini kit (Qiagen) and analyzed on a 7500 Real-
Time PCR system (Applied Biosystems). RNA levels were normalized against the
corresponding levels of β-actin mRNA. Primers for real-time PCR were purchased
from TaKaRa.
Immunostaining and LysoTracker staining. NSCs were fixed with 4% PFA in
PBS, permeabilized with 0.1% Triton X-100 in PBS, blocked in 5% normal goat
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serum (NGS)/0.1% Triton X-100 in PBS, and stained with the following antibodies:
rat anti-Lamp1 (1D4B; Developmental Studies Hybridoma Bank), rabbit anti-
EGFR, mouse anti–Ki-67, rabbit anti-Sox2, mouse anti-Nestin (BD Pharmingen),
rabbit anti-GFAP (Sigma), and rabbit anti-TFEB (Bethyl) (primary) and Alexa
Fluor-conjugated goat species-specific anti-IgG (Thermo Fisher Scientific) (sec-
ondary) in 1% NGS/0.1% Triton X-100 in PBS. Images were obtained on an LSM
510 (ZEISS). For processing of brain tissues, mice were transcardially perfused with
4% PFA in PBS. Brains were postfixed with 4% PFA in PBS, cryoprotected by
sequential incubation with 10%, 20%, and 30% sucrose in PBS, and embedded and
frozen in OCT (Tissue TEK). To detect lysosomes, cryosections 20 µm thick were
treated with 10 mM sodium citrate buffer (pH 6.0) at 80 °C for 5 min for antigen
retrieval, cooled at room temperature, blocked with 5% normal donkey serum
(NDS) or NGS/0.1% Triton X-100 in PBS, and stained with the following anti-
bodies: mouse anti–Ki-67, chicken anti-GFP (Abcam), rat anti-GFP (Nacalai
Tesque), rabbit anti-DsRed (Clontech), goat anti-cathepsin B (R&D systems), goat
anti-cathepsin L (R&D systems), or rat anti-Lamp1 (primary antibodies), followed
by Alexa Fluor-conjugated donkey or goat species-specific anti-IgG (secondary
antibodies), in 1% NDS or NGS containing 0.1% Triton in PBS. Secondary anti-
bodies were conjugated with Alexa Fluor 405 for Ki-67, Alexa Fluor 488 for GFP,
Alexa Fluor 594 for mCherry, and Alexa Fluor 647 for cathepsins and Lamp1. In
Fig. 4a and Supplementary Fig. 4, we set the colors of Alexa Fluor 647 to red and
Alexa Fluor 594 to blue to clearly depict immunostaining with the Alexa Fluor 647-
conjugated antibody. Confocal z-stack images were obtained on an LSM880
(ZEISS). Figures show projection images. To count NSCs, DCX-positive cells, and
cleaved-caspase-3–positive cells in Tfeb cKO mice, every sixth slice of 50-µm
cryosections taken along the caudal–rostral axis throughout the DG was immu-
nostained by a free floating method. The slices (six per mouse) were blocked with
5% normal donkey serum (NDS) or NGS/0.3% Triton X-100 in PBS, and then
stained with the following antibodies: rabbit anti–Ki-67, mouse anti-GFAP
(Sigma), goat anti-Sox2 (R&D Systems), rabbit anti-Sox2, goat anti-DCX (Santa
Cruz Biotechnology), or rabbit anti–cleaved-caspase-3 (Cell Signaling Technology)
(primary antibodies), followed by Alexa Fluor-conjugated donkey or goat species-
specific anti-IgG (secondary antibodies), in 1% NDS or NGS containing 0.3%
Triton in PBS. Secondary antibodies were conjugated with Alexa Fluor 405 for
GFAP, Alexa Fluor 488 for Ki-67, DCX or cleaved-caspase-3, and Alexa Fluor 647
for Sox2. tdTomato was not stained with an antibody. For BrdU detection, every
sixth slice (total six slices) or every tenth slice (total four slices) of a 50-µm section
was incubated in 2 N HCl for 30 min, neutralized with 0.1 M sodium tetraborate,
and then immunostained with rabbit anti-GFAP, rat anti-BrdU (Serotec), mouse
anti-RFP (Abcam), and goat anti-Sox2 antibodies. Confocal z-stack images through
50-µm sections were obtained on an LSM880 Airy (ZEISS) and analyzed using the
Imaris software (Bitplane). Specificity of TFEB antibody in IHC was confirmed by
immunostaining using liver sections (Supplementary Fig. 10). For LysoTracker
staining to detect lysosomes in vitro, quiescent NSCs were incubated in medium
containing 50 nM LysoTracker Green DND-26 (Invitrogen) for 30 min, and then
observed on an AF6000 microscope after a medium change.
Three-dimensional image analyses using the Imaris software. To quantify
lysosomes in NSC in GFAP-GFP;Nestin-mCherry-NLS double-transgenic mice,
3D images from z-stack images obtained by the confocal microscopy (LSM780
and LSM880) with a ×40 objective were reconstructed in Imaris, and a surface was
first created using the GFP channel to extract GFP-positive cells. Subsequently,
this surface was manually separated in single cells, and the surfaces were used to
quantify cathepsin L signals in each cell type (eight images, 32 cells). To count
NSCs, aNSCs, and DCX-positive cells in conditional knockout mice and controls,
we used the Imaris software to reconstruct 3D images from z-stack images of the
entire medial-lateral length of the DG in a hemisphere, using images obtained by
confocal microscopy (LSM880 Airy) with a ×10 objective. To count NSCs in the
DG, we made a colocalization channel for the tdTomato and Sox2 signals, created
spots, as shown in Fig. 7f, l, for counting from colocalization signals 3 µm in
diameter, excluded the spots in the outside of the SGZ as well as the spots of
astrocytes identified from GFAP staining in the 3D images, and then confirmed
the remains of spots with GFAP expression. To count aNSCs, we made another
colocalization channel for the Ki-67, tdTomato, and Sox2 signals, created spots
from triple-positive signals 3 µm in diameter, and then counted spots only in
NSCs as described above for NSC counting. The same procedure was performed to
count BrdU-positive cells. To count DCX-positive cells, we made a colocalization
channel for DCX and tdTomato, and created spots from double-positive signals
4 µm in diameter. The number of cleaved-caspase-3–positive cells among
tdTomato-positive cells in the SGZ was determined by manual counting. All
quantifications for cell counting were performed through the entire rostrocaudal
length of the DG.
Slice culture, immunostaining, and cell counting. Slice preparation was per-
formed by standard procedures. In brief, brains from 6-month-old GFAP-GFP;
Nestin-NLS-mCherry double-transgenic mice were dropped into cutting solution
(280 mM sucrose, 2 mM KCl, 10 mM HEPES-NaOH [pH 7.4], 0.5 mM CaCl2,
10 mM MgCl2, and 10 mM glucose). After the brain was cut at the midline, regions
including the whole DG were sliced into six 300-µm-thick slices on a vibratome
(Leica, VT1200S), yielding 12 slices of DG from each brain. Slices were incubated
in bath solution (135 mM NaCl, 50 mM KCl, 10 mM CaCl2, 10 mM MgCl2, and
100 mM HEPES-NaOH [pH 7.4]) with bubbling oxygen and transferred on Mil-
licell Cell Culture Inserts (0.4-µm pore size, 30-mm diameter; EMD Millipore) in
six-well culture plates containing culture medium (5% horse serum and 5% FBS in
bath solution). Brain slices were covered with Cellmatrix Type I-A (Nitta Gelatin)
and incubated for 15 h (37°C, 5% CO2, 80% O2). Six slices from each brain
hemisphere were treated with DMSO (control) or 20 nM BafA, which was added to
both the culture medium and gel. Slices were fixed with 4% PFA in PBS, and then
the collagen gel was removed with forceps. Fixed slices were immunostained by
permeabilizing with 0.3% Triton X-100 in PBS, blocking with 5% NGS/0.3% Triton
X-100 in PBS, primary antibody incubation (chicken anti-GFP, mouse anti-RFP
(MBL), and rabbit anti–Ki-67 (Thermo Fisher Scientific) in 2% NGS/0.3% Triton
X-100 in PBS), washing with 5% bovine serum albumin in PBS, and secondary
antibody incubation (Alexa Fluor 488-conjugated goat anti-chicken, Alexa Fluor
594-conjugated goat anti-mouse, and Alexa Fluor 647-conjugated goat anti-rabbit
with DAPI in 2% NGS/0.3% Triton X-100 in PBS). Samples were fixed again for
5 min in 4% PFA in PBS, and then incubated in CUBIC1 solution (25% urea, 25%
NNN′N′-tetrakis (2-hydroxypropyl) ethylenediamine [Quadrol], 15% Triton X-
100) to make them transparent for imaging52. These experiments used ten 6-
month-old dTg mice. For counting of triple-positive cells, confocal z-stack images
through 300-µm-thick slices were obtained on an LSM780 (ZEISS) or LSM880.
Manual counts were performed in a blinded fashion through the whole SGZ using
the ZEN2.1 software (black edition, ZEISS). Charts in Fig. 4e, f show total numbers
of aNSCs and NSCs per brain hemisphere.
Statistical analysis. Results are presented as means ± s.e.m. Statistical analyses
were performed using the KaleidaGraph software. Statistical differences were
examined using Student’s t-test and one-way ANOVA: P values < 0.05 were con-
sidered significant. All experiments were performed in duplicate or triplicate.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Microarray data that support the findings of this study have been deposited in Gene
Expression Omnibus with the accession codes GSE130018. Our microarray results
(Supplementary Data 1 and 2), movies (Supplementary Movies 1 and 2), and all western
blots with molecular weight markers were provided as Source Data Files. All other
relevant data are available from the corresponding author (T.K.) upon reasonable
request.
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